New York Presbyterian Hospital (Cornell Campus) Pediatric Hematology/Oncology

Topics

• Ocular Oncology and Treatments 420
• Sarcoma Diagnosis and Treatment 394
• Neuroblastoma Research and Treatments 313
• Hematopoietic Stem Cell Transplantation 286
• Glioma Diagnosis and Treatment 191
• CAR-T cell therapy research 128
• Childhood Cancer Survivors' Quality of Life 121
• Hemoglobinopathies and Related Disorders 107
• Acute Myeloid Leukemia Research 89
• Acute Lymphoblastic Leukemia research 85
• Lymphoma Diagnosis and Treatment 76
• Management of metastatic bone disease 76

Most cited

1. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

   The New England journal of medicine · 2021 · 1,440 citations · Sujit Sheth

2. Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.

   Lancet (London, England) · 2025 · 275 citations · Leonid Dubrovsky

3. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.

   Lancet (London, England) · 2021 · 1,369 citations · Pooja Bhagia

4. Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 213 citations · Nicole McNeer

5. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.

   The Lancet. Oncology · 2023 · 629 citations · Pooja Bhagia

6. Targeted drug delivery strategies for precision medicines.

   Nature reviews. Materials · 2021 · 721 citations ·